Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #77781
advertisement
Jin ZB
5
Showing records 1 to 5 |
Display all abstracts from
Jin ZB
124786
Deep Learning-Enabled Vasculometry Depicts Phased Lesion Patterns in High Myopia Progression
He HL
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2024; 13: 100086
124041
MFRP, PRSS56, and MYRF account for 60.5% of a Chinese cohort with nanophthalmos
Tao J
Clinical and Experimental Ophthalmology
2024; 0:
124786
Deep Learning-Enabled Vasculometry Depicts Phased Lesion Patterns in High Myopia Progression
Liu YX
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2024; 13: 100086
124041
MFRP, PRSS56, and MYRF account for 60.5% of a Chinese cohort with nanophthalmos
Jin ZB; Shen RJ
Clinical and Experimental Ophthalmology
2024; 0:
124786
Deep Learning-Enabled Vasculometry Depicts Phased Lesion Patterns in High Myopia Progression
Liu H; Zhang X; Song H; Xu TZ; Fang Y; Ma Y; Ren HY; Ling SG; Dong Z; Xu J; Qin L; Wong TY; Ang M; Jin ZB
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2024; 13: 100086
Issue
25-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept